Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. (Q48148420)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. |
scientific article |
Statements
1 reference
Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. (English)
1 reference
1 reference
Claudia Trenkwalder
1 reference
Birgit Högl
1 reference
Richard P Allen
1 reference
Heike Beneš
1 reference
Ludger Grote
1 reference
Diego García-Borreguero
1 reference
Michael Hopp
1 reference
Björn Bosse
1 reference
Alexander Oksche
1 reference
Karen Reimer
1 reference
Ralf Kohnen
1 reference
RELOXYN Study Group
1 reference
18 October 2013
1 reference
1 reference
12
1 reference
1141-1150
1 reference
12
1 reference
Identifiers
1 reference
1 reference